JANX
Work Here?
Overview
About JANX
Simplify's Rating
Why JANX is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation
Industries
Consulting
Industrial & Manufacturing
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
Parma, Ohio
Founded
1981
Simplify's Take
What believers are saying
- BMS collaboration provides $35M upfront plus development, regulatory, and commercial milestones.
- JANX008 Phase 1 enrollment and JANX011 first-in-human dosing advance clinical validation.
- Tumor-activated approach reduces off-target toxicity versus conventional T cell therapies.
What critics are saying
- BMS termination or deprioritization eliminates material funding and validation signal.
- JANX011 Phase 1 adverse events or efficacy failure damages platform credibility.
- Clinical-stage biotech requires continuous capital raises; market downturns force dilution.
What makes JANX unique
- TRACTr platform selectively activates T cells against tumor antigens with precision engineering.
- Dual-pipeline approach targets both cancer and autoimmune diseases with same core technology.
- Bristol Myers Squibb validation and $35M milestone payment demonstrate platform credibility.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
JANX is Hiring for 2 Jobs on Simplify!
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →
About JANX
Simplify's Rating
Why JANX is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation
Industries
Consulting
Industrial & Manufacturing
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
Parma, Ohio
Founded
1981
JANX is Hiring for 2 Jobs on Simplify!
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →